focus -WSS

focus

author：Wikipedia 2025-09-06 03:32:22 - browse：5473

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： What drug price negotiations mean for Medicare Part D

WSS

Why Novartis is changing the name of its research labs

Eisai exec who led development of Alzheimer’s drug to retire

ACA's risk program benefits Blue Cross Blue Shield insurers

ACA's risk program benefits Blue Cross Blue Shield insurers

Medicare wants to send $9 billion to 340B hospitals

Presidential fundraising highlights so far: Trump brings in more than DeSantis

leisure time

focus

explore

Alkermes shareholders re

ACA's risk program benefits Blue Cross Blue Shield insurers

BioMarin wins approval for gene therapy to treat hemophilia A

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

How one medical school became remarkably diverse

ALS advocates say criticism of new drugs misses bigger picture

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The (many) problems with a new study criticizing cancer screening

After affirmative action ruling, medical educators look to 'holistic review'

ALS advocates say criticism of new drugs misses bigger picture

entertainment

Parents surprise family after baby discharged from NICU after 170 days

Biden targets hefty hospital 'facility fees' that often surprise patients

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Biden targets hefty hospital 'facility fees' that often surprise patients

Why Novartis is changing the name of its research labs

focus

focus

explore

hotspot